NeurIPS25: DoseSurv: Predicting Personalized Survival Outcomes under Continuous-Valued Treatments
Congratulations to Mortiz Gogl whose paper “DoseSurv: Predicting Personalized Survival Outcomes under Continuous-Valued Treatments” was accepted for NeurIPS 2025. A copy of the paper can be found on the NeurIPS25 website.
